Our Grantees

anthony letai

Anthony G. Letai, M.D., Ph.D.

Dana-Farber Cancer Institute, Harvard University Detecting blocks in Apoptosis in Leukemia Stem Cells...more

alizadeh11

Arash Ash Alizadeh, M.D., Ph.D.

Stanford University School of MedicineProspective Validation and Genetic Basis of a Novel Molecular Risk Predictor for Diffuse large B-Cell Lymphoma...more

ari melnick

Ari M. Melnick, M.D.

Albert Einstein College of Medicine The Bcl-6 oncoprotein as a target for transcription therapy...more

banerjee11

Arnob Banerjee, M.D., Ph.D.

University of Maryland School of MedicineGenomic and Functional Identification of Critical Targets in Peripheral T Cell Lymphoma...more

ebert11

Benjamin L. Ebert, M.D., Ph.D.*

Dana-Farber Cancer InstituteIdentification of genetic dependencies in leukemia stem cells...more

boglarka gyukorcza

Boglarka Gyurkocza, M.D.

Fred Hutchinson Cancer Research CenterReducing Relapse of Acute Myeloid Leukemia after Hematopoietic Cell Transplantation...more

chengcheng zhang

Chengcheng (Alec) Zhang, Ph.D.

University of Texas, Southwestern Ex Vivo expansion of hematopoietic stem cells for cord blood and allogeneic transplantations...more

chuan he

Chuan He, Ph.D.

The University of Chicago Improving the Efficiency of Alkylation Anticancer Chemotherapies...more

Craig Okada, M.D.

Oregon Health & Science University Tumor Antigen Receptor Vaccines for Active Immunotherapy of T Cell Malignancies...more

david frank

David Frank, M.D., Ph.D.

Dana-Farber Cancer Institute The Development of STAT Inhibitors as Novel Anti-Leukemia Agents: Use of Semi-Random Synthesis Technology...more

david sternberg

David W. Sternberg, M.D., Ph.D.

Mount Sinai School of Medicine Translational Regulation of Gene Expression in Acute Myelogenous Leukemia (AML)...more

dawn lemanne

Dawn Lemanne, M.D., MPH

Memorial Sloan-Kettering Cancer CenterA Randomized Trial of Physical-Activity Motivation in Breast Cancer Patients....more

sipkins11

Dorothy Sipkins, M.D., Ph.D.*

The University of ChicagoRegulation of Leukemia Cell Dormancy by the Bone Marrow Microenvironment...more

douglas graham

Douglas K. Graham, M.D., Ph.D.

University of Colorado Health Sciences Center Mer Tyrosine Kinase as a Cooperative Oncogene in Leukemogenesis...more

yang2

Eddy Shih-Hsin Yang, M.D., Ph.D.

University of Alabama-Birmingham Comprehensive Cancer Center Mechanisms by which GSK3β inhibition enhances nonhomologous end-joining repair of IR-induced double strand breaks...more

elizabeth hexner

Elizabeth Hexner, M.D.

Hospital of the University of PennsylvaniaT cells to Enhance Umbilical Cord Blood Transplantation...more

eric carnes

Eric C. Carnes, Ph.D.

University of New Mexico Cancer Research & Treatment Center Targeted Nanotherapeutics for Treatment of Acute Leukemia...more

Fay Young, M.D.

University of Rochester Medical Center Integrin and Chemokine-Mediated Homing During B Cell Ontogeny and Leukemogenesis...more

Gabriel Birrane, Ph.D.

Beth Israel Deaconess Medical Center Investigating the role of the ROBO1 protein in the development of blood cancers...more

george georges

George Georges, M.D.

Fred Hutchinson Cancer Research Center T-Cells to Control the Graft-Versus-Host Effect of Nonmyeloablative Hematopoietic Cell Transplantation...more